Neurodevelopmental Outcomes of Premature Infants with Severe Respiratory Failure Enrolled in a Randomized Controlled Trial of Inhaled Nitric Oxide
To access this article, please choose from the options below
INO Therapeutics provided the study gas, gas delivery systems, and site monitoring for all hospitals, and capitation funding for the hospital outside the NICHD Neonatal Research Network. The company was otherwise not involved in the study design, data analysis, data interpretation, or preparation of manuscripts.See funding information available at www.jpeds.com.
PII: S0022-3476(07)00255-7
doi:10.1016/j.jpeds.2007.03.017
© 2007 Mosby, Inc. All rights reserved.
Refers to article:
- Inhaled Nitric Oxide in the Premature Newborn
